Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Mesenchymal Stem Cells01:19

Mesenchymal Stem Cells

4.6K
Mesenchymal stem cells (MSCs) are adult stem cells that can differentiate into most connective tissue cell types, except for hematopoietic cells, depending upon the source of MSCs. For example, bone-marrow-derived MSCs (BM-MSCs) can differentiate into osteocytes, hepatocytes, and pancreatic and neuronal cells. MSCs can be isolated from various sources such as bone marrow, placenta, adipose tissue, teeth, and Wharton’s jelly, a gelatinous substance in the umbilical cord. The ease of their...
4.6K
Stem Cell Therapy for Tissue Regeneration01:21

Stem Cell Therapy for Tissue Regeneration

4.0K
Stem cell therapy is a method used in regenerative medicine to repair and restore function to damaged tissues and organs. Stem cells have the potential to proliferate and differentiate into various tissue types, making them ideal candidates for tissue regeneration. For example, hematopoietic stem cell transplants are commonly used in blood cancer treatment to replenish damaged bone marrow and restore healthy blood cells.
Types of Stem Cells used in Stem Cell Therapy
The two main cell...
4.0K
Stem Cell Culture01:17

Stem Cell Culture

5.0K
Stem cell research aims to find ways to use stem cells to regenerate and repair cellular damage. Over time, most adult cells undergo the wear and tear of aging and lose their ability to divide and repair themselves. Stem cells do not display a particular morphology or function. Adult stem cells, which exist as a small subset of cells in most tissues, keep dividing and can differentiate into a number of specialized cells generally formed by that tissue. These cells enable the body to renew and...
5.0K
iPS Cell Differentiation01:22

iPS Cell Differentiation

2.6K
The ability of induced pluripotent stem cells or iPSCs to differentiate into most body cell types has stimulated repair and regenerative medicine research over the past few decades. iPSC-derived blood cells, hepatocytes, beta islet cells, cardiomyocytes, neurons, and other cell types can repair injuries or regenerate damaged tissue in diseases such as diabetes and neurodegenerative disorders.
2.6K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Explainable AI Consensus for Grading Human Blastocysts and Blastoids.

Reproduction & fertility·2026
Same author

Ginsenoside Rd attenuates renal aging and fibrosis through inhibition of angiotensin II type 1 receptor signaling.

Phytomedicine : international journal of phytotherapy and phytopharmacology·2026
Same author

Differential association of psoas and paraspinal muscle volumes with appendicular lean mass index: AI-derived lumbar computed tomography three-dimensional volumetric indices in older Korean Women: an observational study.

Asian spine journal·2026
Same author

Comparison of Clinical and Radiological Outcomes Between Suction Aspiration and Combination Methods of Mechanical Thrombectomy in Patients With Acute Cerebral Infarction: The COMPETE Trial.

Journal of Korean medical science·2026
Same author

Exosome-Mediated miRNA Delivery Restores Early Differentiation and Survival Programs in DGCR8-Deficient Mouse Embryonic Stem Cells.

International journal of molecular sciences·2026
Same author

Expression of purinergic receptor P2Y, G-protein coupled 2, is regulated by estrogen during the estrous cycle in mouse uterus.

Purinergic signalling·2026

Related Experiment Video

Updated: May 16, 2025

High Throughput Characterization of Adult Stem Cells Engineered for Delivery of Therapeutic Factors for Neuroprotective Strategies
09:19

High Throughput Characterization of Adult Stem Cells Engineered for Delivery of Therapeutic Factors for Neuroprotective Strategies

Published on: January 4, 2015

10.8K

Multipotent Mesenchymal Stem Cell Therapy for Vascular Dementia.

Eun-Young Kim1, Ki-Sung Hong1, Dong-Hun Lee2

  • 1Miraecellbio Co., Ltd., Seoul 04795, Republic of Korea.

Cells
|May 13, 2025
PubMed
Summary

Human embryonic stem cell-derived multipotent mesenchymal stem cells (MMSCs) show promise for treating vascular dementia (VD). MMSCs improved memory and brain health in a mouse model, offering a new therapeutic avenue for this condition.

Keywords:
carotid stenosiscognitive dysfunctionconduct disorderhuman embryonic stem cellsstem cellsvascular dementia

More Related Videos

Preparation of Plasma Membrane Vesicles from Bone Marrow Mesenchymal Stem Cells for Potential Cytoplasm Replacement Therapy
09:34

Preparation of Plasma Membrane Vesicles from Bone Marrow Mesenchymal Stem Cells for Potential Cytoplasm Replacement Therapy

Published on: May 18, 2017

7.5K
Tracking Superparamagnetic Iron Oxide-labeled Mesenchymal Stem Cells using MRI after Intranasal Delivery in a Traumatic Brain Injury Murine Model
10:03

Tracking Superparamagnetic Iron Oxide-labeled Mesenchymal Stem Cells using MRI after Intranasal Delivery in a Traumatic Brain Injury Murine Model

Published on: November 21, 2019

7.6K

Related Experiment Videos

Last Updated: May 16, 2025

High Throughput Characterization of Adult Stem Cells Engineered for Delivery of Therapeutic Factors for Neuroprotective Strategies
09:19

High Throughput Characterization of Adult Stem Cells Engineered for Delivery of Therapeutic Factors for Neuroprotective Strategies

Published on: January 4, 2015

10.8K
Preparation of Plasma Membrane Vesicles from Bone Marrow Mesenchymal Stem Cells for Potential Cytoplasm Replacement Therapy
09:34

Preparation of Plasma Membrane Vesicles from Bone Marrow Mesenchymal Stem Cells for Potential Cytoplasm Replacement Therapy

Published on: May 18, 2017

7.5K
Tracking Superparamagnetic Iron Oxide-labeled Mesenchymal Stem Cells using MRI after Intranasal Delivery in a Traumatic Brain Injury Murine Model
10:03

Tracking Superparamagnetic Iron Oxide-labeled Mesenchymal Stem Cells using MRI after Intranasal Delivery in a Traumatic Brain Injury Murine Model

Published on: November 21, 2019

7.6K

Area of Science:

  • Neuroscience
  • Regenerative Medicine
  • Stem Cell Biology

Background:

  • Vascular dementia (VD) presents significant cognitive and behavioral challenges with limited treatment options.
  • Current stem cell therapies for VD show restricted efficacy in addressing cognitive and behavioral deficits.

Purpose of the Study:

  • To develop and evaluate a novel treatment for VD using human embryonic stem cell-derived multipotent mesenchymal stem cells (MMSCs).
  • To assess the therapeutic potential of MMSCs in a mouse model of VD induced by bilateral carotid artery stenosis (BCAS).

Main Methods:

  • Induction of VD in a mouse model using bilateral carotid artery stenosis (BCAS).
  • Administration of multipotent mesenchymal stem cells (MMSCs) derived from human embryonic stem cells.
  • Evaluation of therapeutic effects through behavioral tests (working and long-term memory).
  • Postmortem brain tissue analysis including mRNA expression and hematoxylin and eosin (H&E) staining.

Main Results:

  • MMSCs treatment significantly enhanced working and long-term memory performance in the VD mouse model.
  • Histological analysis demonstrated increased angiogenesis, preserved blood-brain barrier integrity, and improved hippocampal organization.
  • MMSCs administration led to reduced Rock1/2 expression, suggesting suppression of neuroinflammation and apoptosis.

Conclusions:

  • MMSCs represent a promising and effective therapeutic strategy for vascular dementia.
  • The study highlights the potential of MMSCs in promoting neuroprotection and cognitive recovery in VD.
  • Further research into MMSCs could lead to sustainable treatments for VD patients.